Trials / Conditions / Advanced HR+/HER2- Breast Cancer
Advanced HR+/HER2- Breast Cancer
4 registered clinical trials studyying Advanced HR+/HER2- Breast Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Can NCT07367178 | MedSIR | Phase 2 |
| Recruiting | Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast C NCT07288359 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Recruiting | Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Adv NCT06726148 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED NCT05520723 | MedSIR | Phase 2 |